AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE

AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE was reported 117 times

AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CENTRAL NERVOUS SYSTEM MASS 10 0.1053
1 WALL MOTION SCORE INDEX ABNORMAL 10 0.0909
2 AIRWAY REMODELLING 10 0.0806
3 ATOPY 10 0.0360
4 CARDIAC SEPTAL DEFECT 10 0.0139
5 EOSINOPHILIC MYOCARDITIS 10 0.0137
6 INTRANASAL HYPOAESTHESIA 1 0.0106
7 MICROANGIOPATHY 10 0.0106
8 PULMONARY ARTERY OCCLUSION 1 0.0104
9 VOCAL CORD CYST 1 0.0102
10 SKIN CANCER METASTATIC 1 0.0101
11 INFUSION SITE SCAB 1 0.0081
12 POST-TUSSIVE VOMITING 1 0.0061
13 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 10 0.0049
14 EOSINOPHIL COUNT DECREASED 10 0.0042
15 BLOOD IMMUNOGLOBULIN E INCREASED 10 0.0041
16 DEVICE WIRELESS COMMUNICATION ISSUE 1 0.0039
17 RESPIRATORY SYMPTOM 10 0.0035
18 SMOKE SENSITIVITY 1 0.0032
19 EOSINOPHILIC PNEUMONIA 10 0.0032
20 VENTRICULAR HYPOKINESIA 10 0.0031
21 VASCULAR DEVICE OCCLUSION 1 0.0029
22 CHRONIC SINUSITIS 10 0.0027
23 NSAID EXACERBATED RESPIRATORY DISEASE 1 0.0026
24 INFUSION SITE SCAR 1 0.0023
25 NASAL POLYPS 11 0.0022
26 DEPENDENCE ON OXYGEN THERAPY 1 0.0020
27 CORYNEBACTERIUM INFECTION 1 0.0019
28 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
29 INFUSION SITE DISCHARGE 3 0.0017
30 DIAPHRAGMATIC PARALYSIS 1 0.0017
31 INFUSION SITE HAEMORRHAGE 5 0.0015
32 NASAL OPERATION 1 0.0015
33 SUTURE RELATED COMPLICATION 1 0.0014
34 DEVICE ELECTRICAL FINDING 1 0.0014
35 ANTIBODY TEST ABNORMAL 1 0.0014
36 INFUSION SITE INFECTION 3 0.0013
37 DEVICE INFUSION ISSUE 3 0.0012
38 SCIATIC NERVE INJURY 1 0.0012
39 GIANT CELL ARTERITIS 1 0.0012
40 EOSINOPHIL COUNT INCREASED 10 0.0012
41 ALLERGIC SINUSITIS 1 0.0012
42 TERMINAL INSOMNIA 2 0.0011
43 PRODUCT AFTER TASTE 1 0.0010
44 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
45 PRODUCT COATING ISSUE 1 0.0010
46 INTERVERTEBRAL DISC COMPRESSION 1 0.0010
47 SINUSITIS BACTERIAL 1 0.0009
48 INFUSION SITE BRUISING 2 0.0009
49 INFUSION SITE MASS 1 0.0009
50 MIDDLE EAR EFFUSION 2 0.0009
51 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
52 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
53 CARBON DIOXIDE DECREASED 1 0.0009
54 TONGUE HAEMORRHAGE 1 0.0009
55 INFUSION SITE WARMTH 1 0.0008
56 NODULE 10 0.0008
57 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
58 SUDDEN ONSET OF SLEEP 1 0.0007
59 LYMPHOPENIA 10 0.0007
60 INFUSION SITE PAIN 9 0.0007
61 STEROID DIABETES 1 0.0007
62 OBESITY 10 0.0006
63 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
64 INJECTION SITE INFECTION 2 0.0006
65 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
66 INFUSION SITE ERYTHEMA 5 0.0006
67 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
68 OCULAR HYPERTENSION 1 0.0005
69 HYPOGEUSIA 1 0.0005
70 SEASONAL ALLERGY 7 0.0005
71 INFUSION SITE SWELLING 3 0.0005
72 DEVICE CONNECTION ISSUE 1 0.0005
73 PURULENT DISCHARGE 2 0.0005
74 BLOOD LOSS ANAEMIA 1 0.0004
75 VASCULAR DEVICE INFECTION 2 0.0004
76 MENOPAUSAL SYMPTOMS 1 0.0004
77 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
78 SINUS PAIN 1 0.0004
79 RESPIRATORY TRACT INFECTION 11 0.0004
80 ANGLE CLOSURE GLAUCOMA 1 0.0004
81 NASAL DISORDER 1 0.0004
82 ANIMAL BITE 1 0.0004
83 LACRIMATION INCREASED 11 0.0004
84 DRUG TOLERANCE DECREASED 1 0.0004
85 OXYGEN SATURATION ABNORMAL 1 0.0004
86 DERMATITIS CONTACT 4 0.0004
87 PSEUDOMONAS INFECTION 3 0.0003
88 FOREIGN BODY IN THROAT 1 0.0003
89 INFUSION SITE PRURITUS 1 0.0003
90 POLYMYALGIA RHEUMATICA 1 0.0003
91 VIRAL INFECTION 10 0.0003
92 POSTOPERATIVE WOUND INFECTION 2 0.0003
93 PRODUCTIVE COUGH 14 0.0003
94 HAEMATURIA 10 0.0003
95 HAEMORRHAGIC DIATHESIS 1 0.0003
96 SKIN WEEPING 1 0.0003
97 DEVICE KINK 1 0.0003
98 PARANASAL SINUS HYPERSECRETION 1 0.0003
99 BOWEL MOVEMENT IRREGULARITY 2 0.0003
100 THYROID MASS 1 0.0003
101 MULTIPLE ALLERGIES 2 0.0003
102 FUNGAL SKIN INFECTION 1 0.0002
103 TENSION HEADACHE 1 0.0002
104 RHINITIS ALLERGIC 1 0.0002
105 IRON DEFICIENCY 1 0.0002
106 ABDOMINAL HERNIA 1 0.0002
107 ARTHRITIS INFECTIVE 1 0.0002
108 RENAL DISORDER 10 0.0002
109 SARCOIDOSIS 1 0.0002
110 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
111 PRODUCT SIZE ISSUE 1 0.0002
112 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
113 HYDROCEPHALUS 1 0.0002
114 RALES 1 0.0002
115 GASTROENTERITIS VIRAL 3 0.0002
116 TYPE 1 DIABETES MELLITUS 1 0.0002
117 NOCTURIA 2 0.0002
118 CARPAL TUNNEL SYNDROME 2 0.0001
119 ARTHROPOD BITE 1 0.0001
120 HAEMORRHAGIC STROKE 1 0.0001
121 PRODUCT USE COMPLAINT 2 0.0001
122 SCIATICA 2 0.0001
123 PROSTATE CANCER 10 0.0001
124 ASTHMA 14 0.0001
125 HYPERAESTHESIA 1 0.0001
126 SENSATION OF FOREIGN BODY 1 0.0001
127 SKIN SWELLING 1 0.0001
128 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
129 PURPURA 1 0.0001
130 OROPHARYNGEAL DISCOMFORT 1 0.0001
131 INCREASED TENDENCY TO BRUISE 1 0.0001
132 IRON DEFICIENCY ANAEMIA 1 0.0001
133 MIDDLE INSOMNIA 2 0.0001
134 SPUTUM DISCOLOURED 1 0.0001
135 PRODUCT PACKAGING ISSUE 1 0.0001
136 POST PROCEDURAL COMPLICATION 2 0.0001
137 DIZZINESS POSTURAL 1 0.0001
138 AUTOIMMUNE DISORDER 1 0.0001
139 SINUS DISORDER 2 0.0001
140 LIMB DISCOMFORT 3 0.0001
141 TEMPERATURE INTOLERANCE 1 0.0001
142 TENDERNESS 1 0.0001
143 HAEMORRHAGE 10 0.0001
144 INJECTION SITE DISCOMFORT 1 0.0001
145 HEREDITARY ANGIOEDEMA 1 0.0001
146 PHARYNGITIS STREPTOCOCCAL 1 0.0001
147 NEPHROPATHY TOXIC 1 0.0001
148 REBOUND EFFECT 1 0.0001
149 NEOPLASM 1 0.0001
150 BLOOD IRON DECREASED 1 0.0001
151 WRIST FRACTURE 1 0.0001
152 BURSITIS 1 0.0001
153 INTRAOCULAR PRESSURE INCREASED 1 0.0001
154 ORAL CANDIDIASIS 1 0.0001
155 TOOTH INFECTION 1 0.0001
156 EAR INFECTION 2 0.0001
157 SINUS CONGESTION 1 0.0001
158 PALLOR 2 0.0001
159 GINGIVAL BLEEDING 1 0.0001
160 DEVICE MECHANICAL ISSUE 1 0.0001
161 PERIPHERAL COLDNESS 1 0.0001
162 MEMORY IMPAIRMENT 10 0.0001
163 HUNGER 1 0.0001
164 DEVICE LEAKAGE 3 0.0001
165 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
166 THROAT IRRITATION 3 0.0001
167 RESPIRATORY DISORDER 2 0.0001
168 HYPOAESTHESIA ORAL 1 0.0001
169 DEVICE FAILURE 1 0.0001
170 INSURANCE ISSUE 1 0.0001
171 MUSCULOSKELETAL CHEST PAIN 1 0.0001
172 BRAIN FOG 1 0.0001
173 CYANOSIS 1 0.0001
174 RESPIRATORY TRACT CONGESTION 1 0.0001
175 NIGHT SWEATS 2 0.0001
176 CONFUSIONAL STATE 10 0.0001
177 MULTIPLE FRACTURES 1 0.0001
178 STAPHYLOCOCCAL INFECTION 2 0.0001
179 PHOTOSENSITIVITY REACTION 1 0.0001
180 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
181 MUSCULOSKELETAL DISCOMFORT 1 0.0001
182 DEVICE DEFECTIVE 1 0.0001
183 HYPOXIA 2 0.0001
184 DRUG ERUPTION 1 0.0001
185 GOUT 1 0.0001
186 OXYGEN SATURATION DECREASED 3 0.0001
187 DYSPNOEA EXERTIONAL 2 0.0001
188 FEELING JITTERY 1 0.0001
189 ACUTE RESPIRATORY FAILURE 1 0.0001
190 EAR PAIN 1 0.0001
191 ORAL HERPES 1 0.0001
192 WHEEZING 3 0.0001
193 CATARACT 3 0.0001
194 BLOOD PRESSURE ABNORMAL 1 0.0001
195 FEEDING DISORDER 1 0.0000
196 HYPERTENSION 10 0.0000
197 IRRITABLE BOWEL SYNDROME 1 0.0000
198 POOR QUALITY SLEEP 1 0.0000
199 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
200 RASH PAPULAR 1 0.0000
201 SNEEZING 1 0.0000
202 THERAPY NON-RESPONDER 2 0.0000
203 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
204 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
205 PRODUCT AVAILABILITY ISSUE 1 0.0000
206 SHOCK 1 0.0000
207 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
208 COUGH 12 0.0000
209 LUNG DISORDER 2 0.0000
210 AGEUSIA 1 0.0000
211 UNEVALUABLE EVENT 3 0.0000
212 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
213 SINUSITIS 4 0.0000
214 ILLNESS 4 0.0000
215 SKIN ULCER 1 0.0000
216 EXPOSURE VIA SKIN CONTACT 1 0.0000
217 DEAFNESS 1 0.0000
218 PNEUMONIA 12 0.0000
219 CONDITION AGGRAVATED 11 0.0000
220 DIVERTICULITIS 1 0.0000
221 FEELING COLD 1 0.0000
222 HAEMOPTYSIS 1 0.0000
223 EYE PAIN 2 0.0000
224 PAIN IN JAW 1 0.0000
225 INTENTIONAL DOSE OMISSION 1 0.0000
226 EYE IRRITATION 2 0.0000
227 INFECTION 5 0.0000
228 NEEDLE ISSUE 1 0.0000
229 NASAL CONGESTION 2 0.0000
230 BLOOD POTASSIUM DECREASED 1 0.0000
231 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
232 THERAPEUTIC RESPONSE DECREASED 2 0.0000
233 HEAD INJURY 1 0.0000
234 HYPOTHYROIDISM 1 0.0000
235 MOVEMENT DISORDER 1 0.0000
236 CHOLELITHIASIS 1 0.0000
237 EYE DISORDER 1 0.0000
238 HEART RATE INCREASED 3 0.0000
239 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
240 VISUAL ACUITY REDUCED 1 0.0000
241 DEHYDRATION 4 0.0000
242 NEOPLASM MALIGNANT 2 0.0000
243 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
244 CHEST DISCOMFORT 3 0.0000
245 DEVICE USE ERROR 1 0.0000
246 SLEEP DISORDER 2 0.0000
247 DYSPNOEA 16 0.0000
248 BRONCHITIS 2 0.0000
249 HOT FLUSH 2 0.0000
250 PARAESTHESIA 4 0.0000
251 INJECTION SITE HAEMORRHAGE 2 0.0000
252 HYPOTENSION 5 0.0000
253 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
254 EXTRA DOSE ADMINISTERED 1 0.0000
255 PSORIATIC ARTHROPATHY 1 0.0000
256 INFLUENZA LIKE ILLNESS 2 0.0000
257 ROAD TRAFFIC ACCIDENT 1 0.0000
258 DEVICE DISLOCATION 1 0.0000
259 SEPTIC SHOCK 1 0.0000
260 INJECTION SITE PAIN 7 0.0000
261 COVID-19 4 0.0000
262 PULMONARY OEDEMA 1 0.0000
263 GASTROINTESTINAL DISORDER 2 0.0000
264 HYPOKALAEMIA 1 0.0000
265 OROPHARYNGEAL PAIN 2 0.0000
266 CHEST PAIN 4 0.0000
267 BLOOD CHOLESTEROL INCREASED 1 0.0000
268 ARRHYTHMIA 1 0.0000
269 OCULAR HYPERAEMIA 1 0.0000
270 DISEASE RECURRENCE 1 0.0000
271 RASH ERYTHEMATOUS 1 0.0000
272 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
273 PRODUCT DOSE OMISSION ISSUE 6 0.0000
274 CELLULITIS 1 0.0000
275 BLOOD PRESSURE INCREASED 3 0.0000
276 ECZEMA 1 0.0000
277 WEIGHT INCREASED 4 0.0000
278 RHEUMATOID ARTHRITIS 2 0.0000
279 URINARY TRACT INFECTION 3 0.0000
280 INCORRECT DOSE ADMINISTERED 4 0.0000
281 PRODUCT SUBSTITUTION ISSUE 1 0.0000
282 SEIZURE 2 0.0000
283 SURGERY 1 0.0000
284 OEDEMA PERIPHERAL 2 0.0000
285 VERTIGO 1 0.0000
286 NASOPHARYNGITIS 3 0.0000
287 EXPOSURE DURING PREGNANCY 1 0.0000
288 LOSS OF CONSCIOUSNESS 2 0.0000
289 RHINORRHOEA 1 0.0000
290 PSORIASIS 2 0.0000
291 FALL 5 0.0000
292 SOMNOLENCE 3 0.0000
293 HEPATIC ENZYME INCREASED 1 0.0000
294 ERYTHEMA 3 0.0000
295 ABDOMINAL PAIN UPPER 3 0.0000
296 DEVICE MALFUNCTION 1 0.0000
297 MOBILITY DECREASED 1 0.0000
298 EPISTAXIS 1 0.0000
299 HYPOAESTHESIA 2 0.0000
300 DIABETES MELLITUS 1 0.0000
301 INJECTION SITE SWELLING 1 0.0000
302 PERIPHERAL SWELLING 2 0.0000
303 BACK PAIN 3 0.0000
304 DRUG DOSE OMISSION BY DEVICE 1 0.0000
305 HEADACHE 8 0.0000
306 ARTHRITIS 1 0.0000
307 INJECTION SITE BRUISING 1 0.0000
308 CARDIAC FAILURE CONGESTIVE 1 0.0000
309 TREMOR 2 0.0000
310 DIZZINESS 6 0.0000
311 URTICARIA 2 0.0000
312 ABDOMINAL DISCOMFORT 2 0.0000
313 RENAL IMPAIRMENT 1 0.0000
314 BALANCE DISORDER 1 0.0000
315 FATIGUE 9 0.0000
316 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
317 MUSCULOSKELETAL STIFFNESS 1 0.0000
318 TACHYCARDIA 1 0.0000
319 DEVICE ISSUE 1 0.0000
320 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
321 MUSCLE SPASMS 2 0.0000
322 CARDIAC DISORDER 1 0.0000
323 PRODUCT USE ISSUE 2 0.0000
324 DYSPHAGIA 1 0.0000
325 GAIT DISTURBANCE 2 0.0000
326 PRURITUS 4 0.0000
327 DRUG INTOLERANCE 1 0.0000
328 ATRIAL FIBRILLATION 1 0.0000
329 PAIN IN EXTREMITY 3 0.0000
330 DYSPEPSIA 1 0.0000
331 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
332 ARTHRALGIA 4 0.0000
333 ABDOMINAL DISTENSION 1 0.0000
334 PLATELET COUNT DECREASED 1 0.0000
335 INFLUENZA 1 0.0000
336 THROMBOCYTOPENIA 1 0.0000
337 PYREXIA 3 0.0000
338 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
339 DECREASED APPETITE 2 0.0000
340 CHILLS 1 0.0000
341 VISUAL IMPAIRMENT 1 0.0000
342 DRY SKIN 1 0.0000
343 WEIGHT DECREASED 2 0.0000
344 RASH 3 0.0000
345 MALAISE 3 0.0000
346 DRUG INTERACTION 1 0.0000
347 DRUG INEFFECTIVE 8 0.0000
348 MYALGIA 1 0.0000
349 NO ADVERSE EVENT 1 0.0000
350 HYPERSENSITIVITY 1 0.0000
351 ASTHENIA 2 0.0000
352 BLOOD GLUCOSE INCREASED 1 0.0000
353 ANAEMIA 1 0.0000
354 ALOPECIA 1 0.0000
355 NAUSEA 4 0.0000
356 PAIN 3 0.0000
357 INSOMNIA 1 0.0000
358 OFF LABEL USE 3 0.0000
359 DIARRHOEA 2 0.0000
360 VOMITING 1 0.0000
361 DEATH 1 0.0000